Patent ID: 11945787
Assignee: ELA PHARMA LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 15:
16. A method for ameliorating, inhibiting, or reducing the incidence of necrotic cell death in a subject in need thereof, wherein the method comprises administering to the subject a therapeutically effective amount of furan-2-yl(2-(pyrrolidin-1-yl)-4,5-dihydro-1H-imidazol-1-yl)methanone of the following structure:, , or a pharmaceutically acceptable salt thereof;
wherein the subject suffers from cellular necrosis of a cell selected from the group consisting of a bone cell, a brain cell, a cardiac cell, a cartilage cell, an embryonic cell, an epidermal cell, an epithelial cell, a fibroblast, a gastrointestinal cell, a glial cell, a gonadal cell, a hematopoetic cell, a kidney cell, a liver cell, a lung cell, a lymphocyte, a macrophage, a muscle cell, a neuronal cell, a pancreatic cell, a parenchymal cell, a retinal cell, a spleen cell, and a stem cell.